文献速递贫血与红细胞疾病造血干细胞移植与细胞治疗

范可尼贫血患者肝脏异常频繁且持续存在

Liver abnormalities are frequent and persistent in patients with Fanconi anemia.
PubMed 文献 · Blood Adv · 2024-01-01

该单中心回顾性队列纳入97例随访至少10年的范可尼贫血(FA)患者,转氨酶升高者31例(32%),不伴胆红素升高及结构性肝异常;移植受者更常见,全身照射增加风险(OR 15.5,95%CI 2.44-304.54,P=.01),雄激素治疗未增加风险。肝活检和尸检多呈胆汁淤积型损伤伴进行性纤维化,类固醇、免疫抑制及熊去氧胆酸治疗似无获益。

要点

  • 97例FA患者中31例(32%)出现转氨酶升高,不伴胆红素升高及结构性肝异常。
  • 转氨酶升高在移植受者中更常见,全身照射增加风险(OR 15.5,95%CI 2.44-304.54,P=.01),雄激素治疗未增加风险。
  • 有限肝活检和尸检多呈胆汁淤积型损伤伴进行性纤维化,类固醇、免疫抑制及熊去氧胆酸治疗似无获益。

核心结论

  • FA患者肝脏疾病常见,多数FA患儿现已成年,青年期出现终末期肝病意味着迫切需要系统测试潜在疗法。

研究设计与样本

  • 单中心回顾性队列,纳入97例随访至少10年的范可尼贫血患者,回顾性分析肝功能。

主要发现

  • 转氨酶升高31例(32%),不伴胆红素升高,无结构性肝异常证据。
  • 转氨酶升高在移植受者中更常见,在未移植者中亦可见。
  • 全身照射增加风险(OR 15.5,95%CI 2.44-304.54,P=.01),雄激素治疗未增加风险。
  • 多数有限肝活检和尸检材料显示胆汁淤积型肝损伤伴进行性纤维化。
  • 2例长期转氨酶升高患者死于肝衰竭。

关键数值与推荐

  • 转氨酶升高定义及具体阈值原文未报告。
  • 有限数据提示类固醇、其他免疫抑制药物或熊去氧胆酸治疗无获益。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 回顾性研究。
  • 单中心。
  • 肝活检和尸检材料数量有限。
  • 关于治疗的数据有限。
  • 原文结论提出迫切需要系统测试潜在疗法。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Liver disease has not been well described in patients with Fanconi anemia (FA). Improvements in outcomes of transplant mean that more individuals with FA are reaching adulthood and new features of the FA phenotype are being discovered. We performed a retrospective review of liver function in a cohort of 97 patients with FA followed-up for at least 10 years at a single center. We identified a high frequency of transaminitis (n = 31, 32%) without elevation of bilirubin and with no evidence of structural hepatic abnormality in patients with FA. Transaminitis was persistent in many cases, sometimes lasting more than a decade without clinical manifestation, although 2 patients with prolonged transaminitis are deceased from liver failure, indicating important long-term clinical consequences. Transaminitis was found in patients who had and had not received transplant but was more frequent in recipients of transplant. Exposure to total body irradiation increased risk (odds ratio, 15.5 [95% confidence interval, 2.44-304.54]; P = .01), whereas treatment with androgens did not. Review of limited numbers of liver biopsies and autopsy material showed a cholestatic pattern of liver injury, with progressive fibrosis, in the majority of patients. Occurrence in cases without transplant as well as cases with transplant argues against a potential diagnosis of atypical liver graft-versus-host disease. Limited data regarding therapy suggest no benefit from treatment with steroids or other immune suppressive medications or ursodeoxycholic acid. Our data show that liver disease is common in patients with FA, and because most children with FA now reach adulthood, end-stage liver disease in young adulthood means systematic testing of potential therapies is urgently needed.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Snyder AJ, Campbell KM, Lane A, et al. Liver abnormalities are frequent and persistent in patients with Fanconi anemia. Blood Adv. 2024. PMID: 38231120. doi:10.1182/bloodadvances.2023012215

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。